News & Events - Kidney care receives innovation boost


Frazer-Nash has been announced as one of the winners of the Kidney Care Competition. A competition which looked at pioneering solutions to address the life-changing effects of kidney failure.

The 14 winners have been announced today, as part of a £3.6m competition funded by the Department of Health through the Small Business Research Initiative and managed by the National Institute for Health Research Devices for Dignity Healthcare Technology Co-operative (NIHR Devices for Dignity HTC). 

The entry from Frazer-Nash, looked at minimising delays in haemodialysis patient treatment by modelling the "dialysis day". By minimising delays, costs can be reduced while improving patient care.

The aim of the competition is to help the 5,000 people diagnosed with kidney failure every year. There are currently 41,000 patients in England receiving treatment for kidney failure.

The loss of kidney function is a life changing event that can result in life-long dependence on healthcare for the patient. Innovations in earlier diagnosis of kidney disease could reduce the number of affected individuals while others can give patients with kidney failure greater independence and enable treatment closer to home. Although end-stage renal failure affects only 0.05% of the general population it commands 1-2% of the annual NHS Budget.

 

Lord Howe, Health Minister, said:

"Innovation is essential for improving treatments and finding new cures, so I am delighted that the NIHR Devices for Dignity HTC is awarding these funds to help develop technologies that can make a difference to patients suffering with kidney disease. This will also build on Britain's reputation as a world leader in science, research and development. I look forward to learning more about the progress and success of this initiative now that these winners have been announced."

 

David Coyle, a patient who has suffered with kidney disease for over 25 years, was a judge on the competition. David said:

"I was delighted to be asked to use my kidney patient knowledge and experience as a judge on the D4D selection panel to identify innovative ideas to use technology to benefit patients.  The competition has produced some truly excellent technology initiatives which, I believe, will greatly transform patient welfare and facilitate greater independence. D4D has found a winning formula to leverage technology for the benefit of patients at every stage of renal disease."

 

The full list of winners from the SBRI competition are:

  • Frazer-Nash Consultancy Ltd - modelling the "dialysis day" with the aim of minimising delays in haemodialysis patient treatment
  • University of Cambridge and SensorHut Ltd - development of an innovative sensor that can detect early AKI by sensing volatile molecules in the urine, at the bedside
  • Helier Scientific Ltd - development of a sensitive test for urinary K-Cadherin, a marker of kidney disease progression in patients with diabetes
  • Jasmine Media Productions LLP - a virtual 4D technology to increase patient confidence towards vascular access cannulation and promote self-care and home haemodialysis treatment options
  • Patientrack Limited and Western Sussex Hospitals NHS Trust - automated information technology system to calculate risk and alert clinical teams
  • DocCom Careflow - ensuring faster treatment of Acute Kidney Injury using secure messaging to deliver alerts to clinicians in real time and then enabling instant, mobile cross team referrals and conversation
  • UK Renal Data Collaboration - delivering patient results in real time and modules to allow patients to flag up mistakes and changes in their medical records
  • East and North Hertfordshire NHS Trust - a telemedicine platform to reduce patient hospital attendance
  • IF Sensing Ltd - a device for monitoring renal function at home using interstitial fluid allowing out of hospital monitoring of kidney function
  • Atlantis Healthcare - an online support programme using coping exercises to improve self-management in order to delay disease progression and aid shared decision-making around dialysis in order to reduce distress and decisional conflict
  • Randox Laboratories Ltd - a test for Aminoacylase-1, a biosensor for early transplant function
  • University of Leeds - an immunoabsorption system for patients due to have blood group incompatible transplants and can be used simultaneously with haemodialysis, reducing treatment time and time spent in hospital
  • Microsensor Limited - infection sensors that can be incorporated into existing peritoneal dialysis products
  • 365 Response Ltd - a booking app for transport, one key factor for delays in haemodialysis treatment
 
 

SERVICES


Our engineering and technical services include:

 
 
 

© Copyright 2013 Frazer-Nash Consultancy

Close  Close

You appear to be visiting us from United States.

Please click below to select your preferred Frazer-Nash website: